Acurx Pharmaceuticals/$ACXP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Acurx Pharmaceuticals
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Ticker
$ACXP
Sector
Primary listing
Employees
4
Headquarters
Website
ACXP Metrics
BasicAdvanced
$7.5m
-
-$5.32
-1.16
-
Price and volume
Market cap
$7.5m
Beta
-1.16
52-week high
$8.34
52-week low
$1.33
Average daily volume
1m
Financial strength
Current ratio
3.176
Quick ratio
3.141
Profitability
Management effectiveness
Return on assets (TTM)
-87.59%
Return on equity (TTM)
-270.80%
Valuation
Price to book
0.9
Price to tangible book (TTM)
0.9
Price to free cash flow (TTM)
-0.448
Free cash flow yield (TTM)
-223.10%
Free cash flow per share (TTM)
-4.529
Growth
Earnings per share change (TTM)
-69.54%
3-year earnings per share growth (CAGR)
-38.05%
ACXP News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Acurx Pharmaceuticals stock?
Acurx Pharmaceuticals (ACXP) has a market cap of $7.5M as of April 28, 2026.
What is the P/E ratio for Acurx Pharmaceuticals stock?
The price to earnings (P/E) ratio for Acurx Pharmaceuticals (ACXP) stock is 0 as of April 28, 2026.
Does Acurx Pharmaceuticals stock pay dividends?
No, Acurx Pharmaceuticals (ACXP) stock does not pay dividends to its shareholders as of April 28, 2026.
When is the next Acurx Pharmaceuticals dividend payment date?
Acurx Pharmaceuticals (ACXP) stock does not pay dividends to its shareholders.
What is the beta indicator for Acurx Pharmaceuticals?
Acurx Pharmaceuticals (ACXP) has a beta rating of -1.16. This means that it has an inverse relation to market volatility.